国际皮肤性病学杂志
國際皮膚性病學雜誌
국제피부성병학잡지
International Journal of Dermatology and Venereology
2015年
6期
388-391
,共4页
毛秋霞%贾苇雪%肖学敏%李诚让
毛鞦霞%賈葦雪%肖學敏%李誠讓
모추하%가위설%초학민%리성양
白癜风%神经节%临床方案%外用药%光疗法%激光疗法
白癜風%神經節%臨床方案%外用藥%光療法%激光療法
백전풍%신경절%림상방안%외용약%광요법%격광요법
Vitiligo%Ganglia%Clinical protocols%External application drugs%Phototherapy%Laser therapy
节段型白癜风是白癜风的一种亚型,沿皮神经节段分布.与其他类型白癜风相比,其在临床表现、发病机制和治疗等方面均有其自身特点.临床上具有发病早、皮损不对称、进展迅速的特点,很少向其他部位蔓延,很少伴有其他自身免疫病.病因及发病机制尚不明确,目前有神经学说、遗传学说、免疫学说及三步骤理论等.节段型白癜风的一线治疗是避免诱发因素,局部外用糖皮质激素、钙调神经磷酸酶抑制剂、维生素D3衍生物等,快速进展期可考虑系统给予小剂量糖皮质激素;二线治疗为窄谱中波紫外线、准分子激光或氦氖激光等;三线治疗是复色仍不理想,考虑手术治疗.
節段型白癜風是白癜風的一種亞型,沿皮神經節段分佈.與其他類型白癜風相比,其在臨床錶現、髮病機製和治療等方麵均有其自身特點.臨床上具有髮病早、皮損不對稱、進展迅速的特點,很少嚮其他部位蔓延,很少伴有其他自身免疫病.病因及髮病機製尚不明確,目前有神經學說、遺傳學說、免疫學說及三步驟理論等.節段型白癜風的一線治療是避免誘髮因素,跼部外用糖皮質激素、鈣調神經燐痠酶抑製劑、維生素D3衍生物等,快速進展期可攷慮繫統給予小劑量糖皮質激素;二線治療為窄譜中波紫外線、準分子激光或氦氖激光等;三線治療是複色仍不理想,攷慮手術治療.
절단형백전풍시백전풍적일충아형,연피신경절단분포.여기타류형백전풍상비,기재림상표현、발병궤제화치료등방면균유기자신특점.림상상구유발병조、피손불대칭、진전신속적특점,흔소향기타부위만연,흔소반유기타자신면역병.병인급발병궤제상불명학,목전유신경학설、유전학설、면역학설급삼보취이론등.절단형백전풍적일선치료시피면유발인소,국부외용당피질격소、개조신경린산매억제제、유생소D3연생물등,쾌속진전기가고필계통급여소제량당피질격소;이선치료위착보중파자외선、준분자격광혹양내격광등;삼선치료시복색잉불이상,고필수술치료.
Segmental vitiligo,a subtype of vitiligo,is distributed segmentally along cutaneous nerves.Compared with other types of vitiligo,segmental vitiligo has distinctive clinical manifestations,pathogenesis and treatment.It is characterized by early onset,asymmetric skin lesions,rapid progression,and low likelihood of spreading to other sites or being accompanied by other autoimmune diseases.The etiology and pathogenesis of segmental vitiligo remain unclear,and several hypotheses have been put forward,such as the neural theory,genetic theory,immunological theory and a new three-step theory.The first-line treatment of segmental vitiligo is avoidance of causative factors,topical application of glucocorticoids,calcineurin inhibitors,vitamin D3 derivatives,and oral administration of a small dose of glucocorticoids at rapid progression stage.The second-line treatment is narrow-band ultraviolet B,excimer laser or helium-neon laser,etc.Surgery may serve as the third-line treatment when repigmentation is unsatisfying.